26 Programs

  • The Implications of Recent Datasets for the Current and Future Management of Breast Cancer — An ASCO 2025 Review

    Explore program
  • Inside the Issue: Managing Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies — Part 1

    Explore program
    • September 2025 1.25 ABIM MOC, ABS MOC, CME 57min
      • H
      • N
      • R
      • +1
      Dr Lee, Dr Pasricha, Dr Dent, T Richards
  • Selection and Sequencing of Therapy for Metastatic Triple-Negative Breast Cancer

    Explore program
  • Addressing Current Knowledge and Practice Gaps in the Community — Optimizing the Use of Oral Selective Estrogen Receptor Degraders for Metastatic Breast Cancer, Part 1

    Explore program